Livzon Pharmaceutical Group Inc. (SHE:000513)
China flag China · Delayed Price · Currency is CNY
41.19
-0.41 (-0.99%)
Sep 8, 2025, 11:44 AM CST

SHE:000513 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Jan '22 Jan '21 2016 - 2020
Operating Revenue
11,68111,70112,32612,52411,92810,463
Upgrade
Other Revenue
120.81111.73104.45105.89135.8857.34
Upgrade
11,80211,81212,43012,63012,06410,520
Upgrade
Revenue Growth (YoY)
-1.84%-4.97%-1.58%4.69%14.67%12.10%
Upgrade
Cost of Revenue
4,2244,2494,7724,5774,3093,744
Upgrade
Gross Profit
7,5787,5647,6588,0537,7546,777
Upgrade
Selling, General & Admin
3,8343,8694,2554,5454,5483,740
Upgrade
Research & Development
974.751,0331,3351,4271,146884.1
Upgrade
Other Operating Expenses
130.07120.33133.07143.97135.87122.94
Upgrade
Operating Expenses
4,9475,0275,7366,1215,8374,747
Upgrade
Operating Income
2,6312,5361,9211,9321,9172,029
Upgrade
Interest Expense
-72.26-88.61-102.09-97.55-84-25.31
Upgrade
Interest & Investment Income
329.55265.34429.98359.25251.81323.19
Upgrade
Currency Exchange Gain (Loss)
20.910.9410.2356.68-4.28-41.56
Upgrade
Other Non Operating Income (Expenses)
-7.09-6.98-4.42-6.37-4.01-5.89
Upgrade
EBT Excluding Unusual Items
2,9022,7072,2552,2442,0772,280
Upgrade
Gain (Loss) on Sale of Investments
-5-15.44-25.65-75.27-23.038.81
Upgrade
Gain (Loss) on Sale of Assets
45.1345.2-0.170.867.03-1.07
Upgrade
Asset Writedown
-19.66-19.86-2.43-13.99-6.15-6.9
Upgrade
Other Unusual Items
102.9589.08155.76174.68191.12208.76
Upgrade
Pretax Income
3,0262,8062,3832,3312,2462,489
Upgrade
Income Tax Expense
524.86501.66485.07374.97293.59358.11
Upgrade
Earnings From Continuing Operations
2,5012,3041,8981,9561,9522,131
Upgrade
Minority Interest in Earnings
-329.79-243.3956.05-46.17-176.42-416.42
Upgrade
Net Income
2,1712,0611,9541,9091,7761,715
Upgrade
Net Income to Common
2,1712,0611,9541,9091,7761,715
Upgrade
Net Income Growth
9.10%5.50%2.32%7.53%3.54%31.62%
Upgrade
Shares Outstanding (Basic)
907920929935935936
Upgrade
Shares Outstanding (Diluted)
907920931936936939
Upgrade
Shares Change (YoY)
-2.04%-1.10%-0.56%-0.04%-0.25%0.41%
Upgrade
EPS (Basic)
2.392.242.102.041.901.83
Upgrade
EPS (Diluted)
2.392.242.102.041.901.83
Upgrade
EPS Growth
11.34%6.64%2.94%7.47%3.73%31.66%
Upgrade
Free Cash Flow
2,4492,4092,4281,833593.231,514
Upgrade
Free Cash Flow Per Share
2.702.622.611.960.631.61
Upgrade
Dividend Per Share
1.1001.1001.3501.6001.3001.250
Upgrade
Dividend Growth
-18.52%-18.52%-15.63%23.08%4.00%8.70%
Upgrade
Gross Margin
64.21%64.03%61.61%63.76%64.28%64.41%
Upgrade
Operating Margin
22.30%21.47%15.46%15.30%15.89%19.29%
Upgrade
Profit Margin
18.40%17.45%15.72%15.12%14.72%16.30%
Upgrade
Free Cash Flow Margin
20.75%20.39%19.54%14.51%4.92%14.39%
Upgrade
EBITDA
3,1903,0862,7402,5632,3422,421
Upgrade
EBITDA Margin
27.03%26.12%22.05%20.29%19.41%23.01%
Upgrade
D&A For EBITDA
558.92549.3818.8630.56425.02391.69
Upgrade
EBIT
2,6312,5361,9211,9321,9172,029
Upgrade
EBIT Margin
22.30%21.47%15.46%15.30%15.89%19.29%
Upgrade
Effective Tax Rate
17.35%17.88%20.36%16.09%13.07%14.38%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.